Stage Iiib Cardiac Al Amyloidosis clinical trials

Explore recruiting stage iiib cardiac al amyloidosis clinical trials.

Also recruiting in Europe

Stage Iiib Cardiac Al Amyloidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Naïve Patients with Mayo Stage IIIb AL Amyloidosis

Germany, Poland, Austria, Italy, Czechia, France +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stage Iiib Cardiac Al Amyloidosis trials by city

Stage Iiib Cardiac Al Amyloidosis in Toronto Stage Iiib Cardiac Al Amyloidosis in Vancouver Stage Iiib Cardiac Al Amyloidosis in Montreal Stage Iiib Cardiac Al Amyloidosis in Calgary Stage Iiib Cardiac Al Amyloidosis in Edmonton Stage Iiib Cardiac Al Amyloidosis in Ottawa Stage Iiib Cardiac Al Amyloidosis in Winnipeg Stage Iiib Cardiac Al Amyloidosis in Quebec City Stage Iiib Cardiac Al Amyloidosis in Hamilton Stage Iiib Cardiac Al Amyloidosis in Kitchener Stage Iiib Cardiac Al Amyloidosis in London Stage Iiib Cardiac Al Amyloidosis in Halifax Stage Iiib Cardiac Al Amyloidosis in New York Stage Iiib Cardiac Al Amyloidosis in Los Angeles Stage Iiib Cardiac Al Amyloidosis in Chicago Stage Iiib Cardiac Al Amyloidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease